Stephanie Loveless has been named the new director of the Center for Deep Listening at Rensselaer Polytechnic Institute, which stewards the philosophy and practices of sonic awareness pioneered by the late Pauline Oliveros.
A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.
The Andy Warhol Foundation for the Visual Arts has awarded the Curtis R. Priem Experimental Media and Performing Arts Center (EMPAC) at Rensselaer Polytechnic Institute a $50,000 grant to support three new works of time-based visual art by Beatriz Santiago Muñoz, Clarissa Tossin, and Ana Navas.
New research, published online today in Developmental Cell, shows that PRC1 – a protein that serves as a telltale sign in many cancer types, including prostate, ovarian, and breast cancer – acts as a “viscous glue” during cell division, precisely controlling the speed at which two sets of DNA are separated as a single cell divides.
TROY, N.Y. — The COVID-19 pandemic has significantly altered how people shop, how much they buy, the trips they take outside their homes, and the number of tele-activities — like work, medicine, and education — that have become commonplace. These changes were rapid and have tremendously impacted the economy, supply chains, and the environment.
Juergen Hahn, the head of the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, has been named a fellow of the American Institute of Chemical Engineers (AIChE), the highest grade of membership. Members are nominated to this position in recognition of significant experience in, and service to, the field of chemical engineering.
TROY, N.Y. — Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human health challenges.
Rensselaer Polytechnic Institute Professor James Hendler has been named to the International Advisory Board of Health Data Research UK, the national institute for health data science, which includes England, Wales, Scotland, and Northern Ireland.